DMEPOS Medicare Audit Guide: Enrollment Moratorium, Prior Authorization, and Documentation Standards
A 2026 guide for DMEPOS suppliers on Medicare audits, including the February to August 2026 enrollment moratorium, the expanded Required Prior Authorization List, probationary prior authorization for new suppliers, documentation standards, and how to respond to DME MAC, UPIC, RAC, and CERT reviews.
KNOWLEDGE CENTER
11/15/202612 min read
Durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) has long been one of the Medicare benefit categories most vulnerable to fraud, waste, and abuse, and 2026 brought the most significant tightening of DMEPOS oversight in years. On February 27, 2026, CMS imposed a six-month nationwide moratorium on new Medicare enrollment for seven categories of medical supply companies. The CY 2026 Home Health Prospective Payment System final rule, effective January 1, 2026, required annual reaccreditation for DMEPOS suppliers, extended the 36-month rule on ownership changes to DMEPOS suppliers, and created a process for exempting compliant suppliers from prior authorization. CMS expanded the Required Prior Authorization List twice in 2026 and launched a probationary prior authorization program for newly enrolled suppliers. The CY 2027 final rule, issued November 4, 2026, added further enrollment and accreditation changes.
At the same time, DMEPOS suppliers continue to face the full range of Medicare audits: DME Medicare Administrative Contractor (DME MAC) medical reviews, Unified Program Integrity Contractor (UPIC) investigations, Recovery Audit Contractor (RAC) reviews, and Comprehensive Error Rate Testing (CERT) reviews.
This article summarizes the 2026 changes, explains the prior authorization and documentation requirements suppliers must meet, and outlines how to respond to audits. It is educational and not legal advice. DMEPOS rules change frequently, so suppliers should confirm current requirements with CMS, their DME MAC, and experienced healthcare counsel.
The 2026 Enrollment Moratorium
What It Covered
Effective February 27, 2026, CMS imposed a six-month nationwide moratorium on Medicare enrollment of new DMEPOS suppliers in seven categories: medical supply company; medical supply company with orthotics personnel; medical supply company with pedorthic personnel; medical supply company with prosthetics personnel; medical supply company with prosthetic and orthotic personnel; medical supply company with registered pharmacist; and medical supply company with respiratory therapist. For moratorium purposes, CMS defined a medical supply company as a business whose principal function is to furnish DMEPOS directly to beneficiaries with a medical order or to other providers and suppliers.
The moratorium applied to new enrollments, including new practice locations of existing suppliers, because each DMEPOS location is separately enrolled. It also applied to changes in majority ownership that require a new enrollment under the 36-month rule and to asset acquisitions requiring a new enrollment. It did not affect existing enrolled suppliers, applications received before the effective date, or routine updates. CMS warned that attempts to circumvent the moratorium by enrolling as another supplier type could lead to denial or revocation and said it would closely screen applications, including through site visits.
Expiration
On August 27, 2026, CMS allowed the moratorium to expire rather than extending it. National Provider Enrollment contractors resumed accepting initial applications for the affected supplier types. CMS's separate enrollment moratorium on new home health agencies and hospices remained in effect, and some states, such as Florida's Medicaid program, imposed their own DMEPOS moratoria.
Lessons From the Moratorium
Although the moratorium has ended, it signals continued scrutiny. CMS may impose moratoria again if it identifies fraud risks, and the CY 2027 final rule clarified aspects of the moratorium framework. New suppliers and suppliers planning acquisitions should expect heightened screening, site visits, and probationary oversight.
Ownership Changes: The 36-Month Rule
The CY 2026 final rule extended the 36-month rule, previously applicable to home health agencies and hospices, to all DMEPOS suppliers. Under this rule, if a DMEPOS supplier undergoes a change in majority ownership within 36 months after its initial enrollment or its most recent change in majority ownership, the supplier's enrollment is terminated, and the supplier must enroll as a new supplier, undergo a survey, and obtain new accreditation, subject to certain exceptions. The CY 2027 final rule added a new denial and revocation ground for suppliers that fail to re-enroll and complete accreditation after such ownership changes. Suppliers and investors must factor these rules into transactions.
Accreditation Changes
Effective January 1, 2026, DMEPOS suppliers must be resurveyed and reaccredited at least once every 12 months, rather than every three years. For suppliers accredited before the rule's effective date, the annual cycle begins when the current three-year accreditation expires. The rule also eliminated the 90-day grace period that allowed accrediting organizations to accredit a new location for an existing supplier without a site visit; all locations must now be surveyed before accreditation. The CY 2027 final rule requires accrediting organizations to report suspected fraud, waste, or abuse to CMS within three calendar days. These changes are discussed in more detail in our companion article on supplier standards and site visits.
Prior Authorization
The Master List and Required Prior Authorization List
CMS maintains a Master List of DMEPOS items potentially subject to face-to-face encounter, written order prior to delivery, and prior authorization requirements. The Required Prior Authorization List, a subset of the Master List, identifies items for which prior authorization is a condition of payment under 42 CFR 414.234.
2026 Expansions
CMS expanded the Required Prior Authorization List twice in 2026:
• A January 13, 2026 Federal Register notice added seven HCPCS codes, five orthoses and two pneumatic compression devices, effective April 13, 2026, and added 18 codes to the Master List.
• A July 2026 notice added eight HCPCS codes, including certain orthoses, a pressure reducing support surface, and a manual wheelchair base. Prior authorization for six of those codes began nationwide on October 28, 2026, and two upper limb orthoses are being implemented in three phases.
The Required Prior Authorization List also includes power mobility devices, lower limb prostheses, certain pressure reducing support surfaces, and other orthoses. Suppliers should download the current list from CMS and confirm the effective date for each code they bill.
Prior Authorization Process
For items on the Required Prior Authorization List, the supplier or treating practitioner submits a prior authorization request to the DME MAC with documentation supporting medical necessity. DME MACs generally decide initial requests within a few business days, and expedited reviews are available in limited circumstances. A provisional affirmation indicates the item is likely to meet coverage requirements, but the claim can still be denied for other reasons, such as technical billing errors. A non-affirmation can be addressed by resubmitting with additional documentation. A claim submitted without a required prior authorization decision will be denied.
Prior Authorization Exemptions
The CY 2026 final rule established a process to exempt suppliers with high provisional affirmation rates from prior authorization requirements for certain items, and to withdraw exemptions if compliance declines. Exempt suppliers remain subject to post-payment review, so documentation must still be complete.
Probationary Prior Authorization for New Suppliers
Beginning October 15, 2026, CMS implemented a one-year probationary prior authorization program, under which newly enrolled DMEPOS suppliers and suppliers undergoing a 100 percent change in ownership must submit prior authorization requests nationwide for specified HCPCS codes, including osteogenesis stimulators and numerous ankle-foot, knee, lower limb, spinal, and upper limb orthoses. New suppliers should confirm whether they are subject to the program and which codes apply.
Documentation Standards
Standard Written Order
Medicare requires a standard written order for DMEPOS items, containing the beneficiary's name or Medicare beneficiary identifier, the order date, a general description of the item, the quantity, the treating practitioner's name or NPI, and the practitioner's signature. For items on the Required Face-to-Face Encounter and Written Order Prior to Delivery List, the order must be received before delivery and the face-to-face encounter must occur within the required timeframe before the order.
Medical Records
The beneficiary's medical record must support the medical necessity of the item under the applicable Local Coverage Determination and policy article. The medical record, not the supplier's own documents, is the primary source of medical necessity support. Supplier-generated forms and attestations generally do not substitute for practitioner documentation.
Face-to-Face Encounter
For items requiring a face-to-face encounter, the treating practitioner's note must document the encounter and the beneficiary's need for the item. The CY 2027 final rule clarified that no new face-to-face encounter is required when a beneficiary needs a replacement item with the same HCPCS code, including a different brand, as long as the documentation from the original encounter is retained.
Proof of Delivery
Suppliers must maintain proof of delivery, such as a signed delivery slip or shipping records with tracking information, showing that the item was delivered to the beneficiary. Proof of delivery must include the beneficiary's name, delivery address, item description, quantity, and date of delivery.
Continued Need and Continued Use
For rental items and recurring supplies, documentation must show continued medical need and continued use, consistent with the applicable policy.
Refill Requirements
For supplies dispensed on a recurring basis, suppliers must contact the beneficiary before each refill to confirm need and must not automatically ship refills. Refill documentation must show the beneficiary's request and the remaining quantity.
Item-Specific Requirements
Many items have specific requirements in their Local Coverage Determinations, such as testing results for oxygen, mobility examinations for power mobility devices, and functional level documentation for lower limb prostheses. Suppliers must know the requirements for every item they furnish.
Medicare Audits of DMEPOS Suppliers
DME MAC Medical Review
DME MACs conduct targeted probe and educate reviews, prepayment reviews, and post-payment reviews based on data analysis. Suppliers with high error rates may be placed on extended prepayment review or referred to UPICs.
UPIC Investigations
UPICs investigate suspected fraud, conduct onsite visits, interview beneficiaries and practitioners, and can recommend payment suspensions, revocations, and referrals to law enforcement. DMEPOS has been a major UPIC focus.
RAC Reviews
Recovery Audit Contractors review DMEPOS claims for approved issues, such as items billed during inpatient stays or exceeding utilization limits.
CERT Reviews
CERT contractors request records for a random sample of claims to calculate the improper payment rate. Failure to respond to CERT requests results in claim denials and overpayment recovery.
Responding to DMEPOS Audits
• Respond to every additional documentation request by the deadline, typically 45 days.
• Obtain complete records from the ordering practitioner, including notes supporting medical necessity.
• Include the order, proof of delivery, prior authorization decision if applicable, and any item-specific documentation.
• Review denials against the applicable LCD and policy article.
• Use the Medicare appeals process: redetermination within 120 days, reconsideration by a Qualified Independent Contractor within 180 days, and further levels.
• Address root causes and educate referral sources.
• Engage counsel when UPIC involvement, payment suspension, or revocation is possible.
Building DMEPOS Audit Readiness
• Maintain current knowledge of the Required Prior Authorization List and Master List.
• Verify orders and practitioner documentation before delivery.
• Use intake checklists for each item type based on LCD requirements.
• Maintain complete proof of delivery.
• Follow refill and continued-need requirements.
• Monitor prior authorization affirmation rates and claim denial rates.
• Conduct internal audits.
• Prepare for annual reaccreditation surveys.
• Report and return overpayments within 60 days.
Common Mistakes
• Delivering items without complete practitioner documentation.
• Relying on supplier-created forms instead of medical records.
• Missing prior authorization for newly added codes.
• Automatically shipping refills.
• Incomplete proof of delivery.
• Missing ADR deadlines.
• Structuring acquisitions without considering the 36-month rule.
Working With Referral Sources
DMEPOS suppliers depend on ordering practitioners for documentation, but practitioners often do not know DMEPOS documentation requirements. Many audit denials result from practitioner notes that do not address the specific coverage criteria. Suppliers can reduce denials by:
• Educating referral sources on the documentation required for each item type, using CMS and DME MAC educational materials.
• Requesting complete records before delivery, rather than after an audit begins.
• Reviewing practitioner documentation against LCD criteria at intake.
• Declining to deliver items when documentation is insufficient, or obtaining an Advance Beneficiary Notice when appropriate.
Suppliers must avoid creating documentation for practitioners or pressuring practitioners to add statements. Supplier-prepared templates and attestations generally do not substitute for practitioner documentation and can raise compliance concerns.
Advance Beneficiary Notices
When a supplier expects that Medicare may deny an item as not reasonable and necessary, it may issue an Advance Beneficiary Notice of Noncoverage before delivery. A properly executed notice allows the supplier to bill the beneficiary if Medicare denies the claim. Notices must be specific, delivered before the item is furnished, and signed by the beneficiary. Routine or blanket notices are not valid.
Competitive Bidding
The CY 2026 final rule revived the DMEPOS Competitive Bidding Program for future rounds, with new processes and products, and the CY 2027 rule updated contract supplier requirements for the Round 2028 program, including disclosure of the country of origin. Suppliers in competitive bidding areas must understand how the program affects which items they can furnish and how they are paid.
Coordinating Communications
Designate staff responsible for prior authorization, documentation requests, and audits, track every deadline, and keep copies of all requests, responses, and decisions.
Payment Suspensions and Revocations
When UPICs identify credible allegations of fraud, CMS may suspend Medicare payments to a supplier under 42 CFR 405.371, often without prior notice. Suspensions can last months or longer and may be accompanied by revocation of billing privileges. Suppliers facing suspension should engage counsel immediately, submit rebuttal statements within the allowed time, and gather documentation showing that items were medically necessary and delivered. Revocation and enrollment issues are discussed further in our companion article on supplier standards.
Balancing Cooperation and Advocacy
Suppliers can cooperate fully with DME MACs and UPICs while appealing denials they believe are wrong. Organized, documented appeals often reverse denials, especially when practitioner records support medical necessity.
Monitoring Performance
Track prior authorization affirmation rates, non-affirmation reasons, claim denial rates by reason, ADR response times, and appeal outcomes by item type and referral source. Use the data to identify documentation gaps, target referral source education, and evaluate eligibility for the prior authorization exemption process. Regular reporting to leadership helps suppliers detect problems before they lead to extended prepayment review or UPIC referral.
Training Intake and Billing Staff
Intake staff should know the documentation requirements for each item type, the current Required Prior Authorization List, and the face-to-face and written order requirements. Billing staff should understand modifiers, prior authorization tracking numbers, and claim requirements. Update training whenever CMS changes the lists or LCDs.
Records Retention
Retain orders, medical records obtained from practitioners, prior authorization decisions, proof of delivery, refill documentation, and correspondence for at least seven years from the date of service, consistent with supplier standards and Medicare requirements, and longer when audits or appeals are pending. Organize records so they can be retrieved quickly by beneficiary, item, and date of service, since ADR deadlines are short and incomplete responses lead to denials.
Preparing for Extended Prepayment Review
When a DME MAC places a supplier on extended prepayment review after high error rates, every claim for the affected items must be supported with documentation before payment. Suppliers should assign a dedicated team, submit complete documentation with each claim, track approval rates, and request education sessions with the DME MAC. Persistent errors can lead to UPIC referral, so treat prepayment review as a priority and address root causes quickly, documenting each corrective step and its results for the record and future audits.
Myths About DMEPOS Audits
Myth: The Moratorium Ended, So Scrutiny Has Eased
The moratorium expired in August 2026, but annual reaccreditation, the 36-month rule, expanded prior authorization, and probationary prior authorization keep scrutiny high.
Myth: Prior Authorization Approval Guarantees Payment
A provisional affirmation can still be followed by denial for technical or other issues, and exempt suppliers remain subject to post-payment review.
Myth: A Signed Order Is Enough
The practitioner's medical record must support medical necessity.
Myth: Replacement Items Always Require a New Face-to-Face Encounter
The CY 2027 rule clarified that same-HCPCS replacements do not require a new encounter if original documentation is retained.
Questions Leadership Should Ask
• Do we know every code on the current Required Prior Authorization List that we bill?
• Are we subject to probationary prior authorization?
• Do we obtain practitioner records before delivery?
• Is our proof of delivery complete?
• Are we prepared for annual reaccreditation?
• Have we evaluated ownership changes under the 36-month rule?
Key Takeaways
• CMS imposed a nationwide moratorium on new enrollment of seven medical supply company types from February 27 to August 27, 2026, and allowed it to expire.
• The CY 2026 final rule requires annual reaccreditation, applies the 36-month rule to DMEPOS suppliers, and creates a prior authorization exemption process, and the CY 2027 rule adds enrollment and accreditation changes.
• CMS expanded the Required Prior Authorization List in April and October 2026 and began probationary prior authorization for new suppliers on October 15, 2026.
• Documentation must include a compliant order, medical records supporting medical necessity, face-to-face documentation where required, proof of delivery, and refill and continued-need records.
• DME MAC, UPIC, RAC, and CERT reviews require timely, complete responses and use of the Medicare appeals process.
How HealthBridge Can Help
HealthBridge helps DMEPOS suppliers navigate Medicare's 2026 changes and respond to audits. Our team can map prior authorization requirements to your product lines, build intake and documentation checklists based on LCDs, audit claims for order, medical necessity, and proof of delivery compliance, and prepare responses and appeals. We also help suppliers prepare for annual reaccreditation, evaluate ownership changes under the 36-month rule, and respond to UPIC inquiries alongside counsel. If your organization supplies DMEPOS to Medicare beneficiaries, please get in touch with us. We will be happy to help you with this topic.
References
• Centers for Medicare & Medicaid Services. Prior Authorization Process for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Items. https://www.cms.gov/data-research/monitoring-programs/medicare-fee-service-compliance-programs/prior-authorization-and-pre-claim-review-initiatives/prior-authorization-process-certain-durable-medical-equipment-prosthetics-orthotics-and-supplies
• Centers for Medicare & Medicaid Services. Required Prior Authorization List. https://www.cms.gov/Research-Statistics-Data-and-Systems/Monitoring-Programs/Medicare-FFS-Compliance-Programs/DMEPOS/Downloads/DMEPOS_PA_Required-Prior-Authorization-List.pdf
• Federal Register. Medicare Program; Updates to the Master List of DMEPOS Items, Required Face-to-Face Encounter and Written Order Prior to Delivery List, and Required Prior Authorization List (January 13, 2026). https://www.govinfo.gov/content/pkg/FR-2026-01-13/html/2026-00487.htm
• Federal Register. Updates to the Master List, Required Face-to-Face Encounter and Written Order Prior to Delivery List, and Required Prior Authorization List (July 2026). https://public-inspection.federalregister.gov/2026-15446.pdf
• Federal Register. Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System Rate Update; DMEPOS Policies (December 2, 2025). https://www.govinfo.gov/content/pkg/FR-2025-12-02/html/2025-21767.htm
• Centers for Medicare & Medicaid Services. CY 2026 HH PPS Final Rule DMEPOS Accreditation Questions and Answers. https://www.cms.gov/files/document/cy-2026-hh-pps.pdf
• Centers for Medicare & Medicaid Services. 2026 New Provider Enrollment Regulations (Medicare Provider Enrollment Compliance Conference, March 2026). https://www.cms.gov/files/document/2026-new-provider-enrollment-regulations.pdf
• Federal Register. Calendar Year 2027 Home Health Prospective Payment System; Medicare Provider Enrollment; DMEPOS Policies, Final Rule (public inspection, November 2026). https://public-inspection.federalregister.gov/2026-22750.pdf
• CGS Administrators, Jurisdiction C DME MAC (CMS contractor). Probationary Period of Prior Authorization for Certain Newly Enrolled DMEPOS Suppliers (September 2, 2026). https://cgsmedicare.com/jc/pubs/news/2026/09/news-210313.html
• Government Accountability Office. Congressional Review Act report on the CY 2026 HH PPS final rule (B-337944). https://www.gao.gov/products/b-337944
• Electronic Code of Federal Regulations. 42 CFR 414.234, Prior authorization for items frequently subject to unnecessary utilization. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-414/subpart-D/section-414.234
• Electronic Code of Federal Regulations. 42 CFR 424.570, Moratoria on newly enrolling Medicare providers and suppliers. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-424/subpart-P/section-424.570
• Electronic Code of Federal Regulations. 42 CFR 410.38, Durable medical equipment: Scope and conditions. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-410/subpart-B/section-410.38

Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.
The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.
HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws. The badges, icons, and achievement graphics displayed on this website represent proprietary performance metrics, volume milestones, and internal corporate recognition issued exclusively by our corporate affiliate network at SummitRidge. These visual markers are utilized solely as historical indicators of enterprise growth, operational longevity, and volume-based milestones cleared within our shared corporate ecosystem.
© 2026 HealthBridge US, a California corporation. All rights reserved.
For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance
